ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 161 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $2,002,000 | -14.4% | 62,928 | -12.7% | 0.07% | -16.5% |
| Q2 2016 | $2,339,000 | -70.5% | 72,062 | -74.6% | 0.08% | -67.3% |
| Q1 2016 | $7,938,000 | -55.1% | 283,899 | -42.7% | 0.26% | -54.7% |
| Q4 2015 | $17,676,000 | -16.6% | 495,830 | -22.6% | 0.57% | -8.0% |
| Q3 2015 | $21,183,000 | -23.0% | 640,552 | -2.5% | 0.62% | -10.7% |
| Q2 2015 | $27,504,000 | +19.7% | 656,741 | -6.9% | 0.70% | +21.1% |
| Q1 2015 | $22,986,000 | -27.8% | 705,301 | -29.6% | 0.58% | -25.1% |
| Q4 2014 | $31,817,000 | +32.1% | 1,002,114 | +3.0% | 0.77% | +26.2% |
| Q3 2014 | $24,093,000 | -6.7% | 973,046 | -14.8% | 0.61% | -2.4% |
| Q2 2014 | $25,810,000 | -15.2% | 1,142,538 | -8.7% | 0.62% | -16.2% |
| Q1 2014 | $30,431,000 | -6.7% | 1,250,764 | -6.7% | 0.75% | -12.1% |
| Q4 2013 | $32,609,000 | -1.5% | 1,340,849 | +11.2% | 0.85% | -5.7% |
| Q3 2013 | $33,119,000 | +83.5% | 1,205,651 | +21.3% | 0.90% | +73.4% |
| Q2 2013 | $18,044,000 | +276.5% | 994,134 | +64.7% | 0.52% | +250.7% |
| Q1 2013 | $4,792,000 | – | 603,532 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |